Schedule 13G ownership disclosure

ACORDA THERAPEUTICS INC

Security class unavailable · CUSIP: 00484M106

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,591,762
Percent of class
6.1800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000790502-15-000005
Form type
SC 13G/A
Filer
Acorda Therapeutics, Inc.
CIK
CIK 1008848
Filed
Jan 06, 2015
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub